Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
Eton Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $15
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $11
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $15
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $10
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $11
Eton Pharmaceuticals Analyst Ratings
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
HC Wainwright & Co. Assumes Eton Pharmaceuticals at Buy, Announces Price Target of $9
Eton Pharmaceuticals Analyst Ratings
H.C. Wainwright Initiates Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $9
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating
Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating